SCHEMBL4345478

SCHEMBL4345478

Cc1c(Cl)cc(N(S)C(=O)Nc2ccc(Cl)cc2)c(O)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
RAB9A P51151 3/20 0.43
PKM P14618 1/20 0.43
NPC1 O15118 4/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
EPHX1 P07099 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
SLC6A2 P23975 1/20 0.38
PDE4A P27815 1/20 0.38
EPHX2 P34913 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRM1 P35372 1/20 0.38
PDE3A Q14432 1/20 0.38
NLRP3 Q96P20 1/20 0.38
ALDH1A1 P00352 2/20 0.38
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4349377 0.90 EGFR (0.41) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4353170 0.88 ALDH1A1 (0.36) RAB9AHTTMEN1KMT2AALDH1A1
SCHEMBL4347869 0.87 MTOR (0.43) RAB9AHTTLMNAMEN1KMT2A
SCHEMBL4353445 0.81 TSHR (0.47) TSHRRAB9APKMNPC1HTT
SCHEMBL4345983 0.77 RAB9A (0.50) TSHRRAB9APKMNPC1HTT
SCHEMBL4343809 0.76 TSHR (0.47) TSHRRAB9APKMNPC1HTT
SCHEMBL4357779 0.76 HTT (0.43) TSHRRAB9ANPC1HTTLMNA
SCHEMBL4347958 0.75 TSHR (0.50) TSHRRAB9APKMNPC1HTT
SCHEMBL4351946 0.75 P2RX1 (0.53) TSHRRAB9APKMNPC1HTT
SCHEMBL4345461 0.75 TSHR (0.44) TSHRRAB9APKMNPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 TSHR 1112/4885RAB9A 4228/4885PKM 333/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 TSHR 1455/4885RAB9A 4588/4885PKM 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.